Roche Gets Genentech in $46.8B Biotech Deal

By Harry Kimball,  Newser Staff
Posted Mar 12, 2009 6:00 AM CDT
Roche Gets Genentech in $46.8B Biotech Deal
A Genentech researcher works on an experiment.   (AP Photo)

Swiss drug giant Roche has succeeded in its quest to own biotech firm Genentech outright, and will purchase the 44% of shares it does not already own for $95 each, the San Francisco Chronicle reports today. The $46.8 billion deal comes after months of haggling, wherein Roche offered as little as $86.50 for shares Genentech valued at $112. Roche pledges to maintain Genentech’s San Francisco campus. (More pharmaceutical companies stories.)

Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X